Anand Devaraj
Overview
Explore the profile of Anand Devaraj including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
150
Citations
4575
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
31.
Dickson J, Hall H, Horst C, Tisi S, Verghese P, Worboys S, et al.
Lung Cancer
. 2022 Sep;
173:94-100.
PMID: 36179541
Lung cancer screening (LCS) eligibility is largely determined by tobacco consumption. Primary care smoking data could guide LCS invitation and eligibility assessment. We present observational data from the SUMMIT Study,...
32.
Denton C, Goh N, Humphries S, Maher T, Spiera R, Devaraj A, et al.
Rheumatology (Oxford)
. 2022 Sep;
62(5):1870-1876.
PMID: 36111858
Objective: To assess associations between the extent of fibrotic interstitial lung disease (ILD) and forced vital capacity (FVC) at baseline and change in FVC over 52 weeks in patients with...
33.
Hewitt R, Bartlett E, Ganatra R, Butt H, Kouranos V, Chua F, et al.
Thorax
. 2022 Aug;
77(11):1149-1151.
PMID: 35940878
Interstitial lung abnormalities (ILA) can be incidentally detected in patients undergoing low-dose CT screening for lung cancer. In this retrospective study, we explore the downstream impact of ILA detection on...
34.
Williams P, Philip K, Gill N, Flannery D, Buttery S, Bartlett E, et al.
Chest
. 2022 Aug;
163(2):455-463.
PMID: 35932889
Background: Lung cancer screening programs provide an opportunity to support people who smoke to quit, but the most appropriate model for delivery remains to be determined. Immediate face-to-face smoking cessation...
35.
Tisi S, Dickson J, Horst C, Quaife S, Hall H, Verghese P, et al.
Eur Respir J
. 2022 Jul;
60(6).
PMID: 35896207
Background: COPD is a major comorbidity in lung cancer screening (LCS) cohorts, with a high prevalence of undiagnosed COPD. Combining symptom assessment with spirometry in this setting may enable earlier...
36.
Dickson J, Hall H, Horst C, Tisi S, Verghese P, Mullin A, et al.
Thorax
. 2022 Jul;
77(10):1036-1040.
PMID: 35863766
Eligibility for lung cancer screening (LCS) requires assessment of lung cancer risk, based on smoking history alongside demographic and medical factors. Reliance on individual face-to-face eligibility assessment risks inefficiency and...
37.
Hall H, Ruparel M, Quaife S, Dickson J, Horst C, Tisi S, et al.
Eur Radiol
. 2022 May;
32(10):6891-6899.
PMID: 35567604
Objectives: Successful lung cancer screening delivery requires sensitive, timely reporting of low-dose computed tomography (LDCT) scans, placing a demand on radiology resources. Trained non-radiologist readers and computer-assisted detection (CADe) software...
38.
Dickson J, Bhamani A, Quaife S, Horst C, Tisi S, Hall H, et al.
Lung Cancer
. 2022 Apr;
168:46-49.
PMID: 35487105
Objectives: Pulmonary nodules are commonly found in Lung Cancer Screening (LCS), with results typically communicated by face-to-face or telephone consultation. Providing LCS on a population basis requires resource efficient and...
39.
Vijayakumar B, Boustani K, Ogger P, Papadaki A, Tonkin J, Orton C, et al.
Immunity
. 2022 Feb;
55(3):542-556.e5.
PMID: 35151371
Some patients hospitalized with acute COVID-19 suffer respiratory symptoms that persist for many months. We delineated the immune-proteomic landscape in the airways and peripheral blood of healthy controls and post-COVID-19...
40.
Buttery S, Williams P, Mweseli R, Philip K, Sadaka A, Bartlett E, et al.
BMJ Open Respir Res
. 2022 Feb;
9(1).
PMID: 35121633
Objectives: Lung cancer screening programmes offer an opportunity to address tobacco dependence in current smokers. The effectiveness of different approaches to smoking cessation in this context has not yet been...